UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
American journal of hematology, ISSN 0361-8609, 10/2014, Volume 89, Issue 10, pp. E176 - E183
Life Sciences & Biomedicine | Hematology | Science & Technology | Acute Disease | Killer Cells, Natural | Humans | Histocompatibility Antigens Class I - immunology | Child, Preschool | Donor Selection - methods | Hematopoietic Stem Cell Transplantation | Genotype | Infant | Male | Graft vs Host Disease - immunology | Neoplasms - therapy | Allografts | Neoplasms - immunology | Adolescent | Adult | Female | Graft vs Host Disease - prevention & control | Unrelated Donors | Neoplasms - pathology | Child | Receptors, KIR - immunology | Killer cells | Transplantation | Analysis | Hematopoietic stem cells | Stem cells | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2425 - 2437
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pyrazoles - therapeutic use | Chlorambucil - adverse effects | Chlorambucil - therapeutic use | Humans | Male | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Diarrhea - chemically induced | Disease-Free Survival | Antineoplastic Agents - adverse effects | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Survival Analysis | Female | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neutropenia - chemically induced | Pyrazoles - adverse effects | Clinical trials | Treatment outcome | Usage | Lymphocytic leukemia | Drug therapy | Analysis | Chronic lymphatic leukemia | Leukemia | Diarrhea | Fatigue | Nausea | Lymphatic leukemia | Lymphoma | Hemorrhage | Survival | Cough | Chlorambucil | Immunosuppression | Chemotherapy | Vomiting | Immunotherapy | Hemoglobin | Myelosuppression | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 03/2020, Volume 188, Issue 6, pp. 898 - 906
indolent lymphoma | rituximab maintenance | first‐line induction immunochemotherapy | Life Sciences & Biomedicine | Hematology | Science & Technology | Toxicity | Mucosa | Rituximab | Prednisone | Lymphoid tissue | Lymphoma | Doxorubicin | Survival | Vincristine | Cyclophosphamide | Mucosal-associated lymphoid tissue | Remission | Neutropenia | Index Medicus | Research Paper | Haematological Malignancy – Clinical
Journal Article
Kardiologia polska (1957), ISSN 0022-9032, 08/2020, Volume 78, Issue 7-8, pp. 780 - 781
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2012, Volume 130, Issue 3, pp. 607 - 612.e9
Allergy and Immunology | eosinophilic leukemia | hypereosinophilia of undetermined significance | classification | criteria | Hypereosinophilic syndrome | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Other diseases. Hematologic involvement in other diseases | Fundamental immunology | Immunopathology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Biological and medical sciences | Medical sciences | Terminology as Topic | Eosinophils - physiology | Hypereosinophilic Syndrome - classification | Eosinophilia - classification | Humans | Eosinophilia - diagnosis | Medical colleges | Platelet-derived growth factor | Parasitic diseases | Analysis | Leukemia | Fibroblast growth factors | Allergic reaction | Public health | Lymphatic system | Disease | Cytokines | Genes | Stem cells | Classification | Thrombosis | Chromosomes | Tumors | Defects | Index Medicus | Abridged Index Medicus | Clinical trials | Conferences | Eosinophilia | Hypersensitivity | Leukocytes (eosinophilic) | Life Sciences
Journal Article
Polskie archiwum medycyny wewne̦trznej, ISSN 0032-3772, 01/2016, Volume 126, Issue 12, pp. 1054 - 1057
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 11, pp. 1863 - 1869
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Immunophenotyping | Male | Survival Rate | Treatment Outcome | Vidarabine - analogs & derivatives | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Remission Induction | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Cladribine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Vidarabine - administration & dosage | Cytogenetic Analysis | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neoplasm Staging | Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 02/2019, Volume 33, Issue 2, pp. 379 - 389
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Survival Rate | Cytarabine - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Myelodysplastic Syndromes - diagnosis | Leukemia, Myeloid, Acute - diagnosis | Benzimidazoles - administration & dosage | Phenylurea Compounds - administration & dosage | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Female | Aged | Drug Therapy, Combination | Myelodysplastic Syndromes - drug therapy | Medical colleges | Chemotherapy | Comparative analysis | Cancer | Slopes | Pneumonia | Myeloid leukemia | Leukemia | Fatigue | Patients | Survival | Myelodysplastic syndrome | Confidence intervals | Randomization | Cytarabine | Risk assessment | Remission | Acute myeloid leukemia | Index Medicus
Journal Article
Polskie archiwum medycyny wewne̦trznej, ISSN 0032-3772, 2018, Volume 128, Issue 7-8, pp. 491 - 493
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 5, pp. 829 - 839
Hematology, Oncology and Palliative Medicine | Missing ligand | Activating killer cell immunoglobulin-like receptors | Bone marrow donor selection | Hematopoietic stem cell transplantation | Malignant diseases | Natural killer cell education | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic Neoplasms - therapy | Receptors, KIR - genetics | Histocompatibility Testing | Humans | Middle Aged | Histocompatibility Antigens Class I - immunology | Child, Preschool | Hematopoietic Stem Cell Transplantation | Graft vs Tumor Effect - immunology | Infant | Male | Histocompatibility Antigens Class I - genetics | Killer Cells, Natural - pathology | Allografts | Adolescent | Killer Cells, Natural - immunology | Adult | Female | Unrelated Donors | Hematologic Neoplasms - genetics | Hematologic Neoplasms - immunology | Graft vs Tumor Effect - genetics | Child | Receptors, KIR - immunology | Killer cells | Hematopoietic stem cells | Stem cells | Cancer | Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 11/2018, Volume 183, Issue 3, pp. 400 - 410
novel anti‐tumour agents | relapsed/refractory | phase IV | Hodgkin lymphoma | brentuximab vedotin | novel anti-tumour agents | Life Sciences & Biomedicine | Hematology | Science & Technology | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Antineoplastic Combined Chemotherapy Protocols | Male | Survival Rate | Immunoconjugates - administration & dosage | Stem Cell Transplantation | Disease-Free Survival | Adolescent | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Aged | Immunoconjugates - adverse effects | Chemotherapy | Transplantation | Lymphomas | Stem cells | Cancer | Transplants & implants | Toxicity | Diarrhea | Radiation therapy | Peripheral neuropathy | Lymphoma | Patients | Survival | Fever | Confidence intervals | Salvage | CD30 antigen | Medical prognosis | Safety | Hodgkin's disease | Neutropenia | Index Medicus
Journal Article